A citation-based method for searching scientific literature

F Stephen Hodi, Steven J O'Day, David F McDermott, Robert W Weber, Jeffrey A Sosman, John B Haanen, Rene Gonzalez, Caroline Robert, Dirk Schadendorf, Jessica C Hassel, Wallace Akerley, Alfons J M van den Eertwegh, Jose Lutzky, Paul Lorigan, Julia M Vaubel, Gerald P Linette, David Hogg, Christian H Ottensmeier, Celeste Lebbé, Christian Peschel, Ian Quirt, Joseph I Clark, Jedd D Wolchok, Jeffrey S Weber, Jason Tian, Michael J Yellin, Geoffrey M Nichol, Axel Hoos, Walter J Urba. N Engl J Med 2010
Times Cited: 9230



Hossein Borghaei, Luis Paz-Ares, Leora Horn, David R Spigel, Martin Steins, Neal E Ready, Laura Q Chow, Everett E Vokes, Enriqueta Felip, Esther Holgado, Fabrice Barlesi, Martin Kohlhäufl, Oscar Arrieta, Marco Angelo Burgio, Jérôme Fayette, Hervé Lena, Elena Poddubskaya, David E Gerber, Scott N Gettinger, Charles M Rudin, Naiyer Rizvi, Lucio Crinò, George R Blumenschein, Scott J Antonia, Cécile Dorange, Christopher T Harbison, Friedrich Graf Finckenstein, Julie R Brahmer. N Engl J Med 2015
Times Cited: 5252




List of shared articles



Times cited

A review of glioblastoma immunotherapy.
Ravi Medikonda, Gavin Dunn, Maryam Rahman, Peter Fecci, Michael Lim. J Neurooncol 2021
25

The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker.
Denis L Jardim, Aaron Goodman, Debora de Melo Gagliato, Razelle Kurzrock. Cancer Cell 2021
21

Development of a Non-IgG PD-1/PD-L1 Inhibitor by in Silico Mutagenesis and an In-Cell Protein-Protein Interaction Assay.
Boyang Ning, Xueli Ren, Kyoji Hagiwara, Shinji Takeoka, Yoshihiro Ito, Hideyuki Miyatake. ACS Chem Biol 2021
2

Characterizing tumor shrinkage as a measure of clinical benefit for immune checkpoint inhibitors.
Thomas Kelleher, Junliang Cai, Nicholas Aj Botwood, Dominic F Labriola. J Immunother Cancer 2021
0

Critically ill patients with severe immune checkpoint inhibitor related neurotoxicity: A multi-center case series.
Prabalini Rajendram, Heather Torbic, Abhijit Duggal, Jeannee Campbell, Michael Hovden, Vikram Dhawan, Stephen M Pastores, Cristina Gutierrez. J Crit Care 2021
0

Palliative care physicians' recognition of patients after immune checkpoint inhibitors and immune-related adverse events.
Yuko Usui, Tomofumi Miura, Takashi Kawaguchi, Kazuhiro Kosugi, Yuko Uehara, Masashi Kato, Toshifumi Kosugi, Miyuki Sone, Naoki Nakamura, Akio Mizushima,[...]. Support Care Cancer 2021
0



Synthetic TILs: Engineered Tumor-Infiltrating Lymphocytes With Improved Therapeutic Potential.
Anaïs Jiménez-Reinoso, Daniel Nehme-Álvarez, Carmen Domínguez-Alonso, Luis Álvarez-Vallina. Front Oncol 2021
2


Sex-related differences in the efficacy of immune checkpoint inhibitors in malignancy: a systematic review and meta-analysis.
Li-Ting Lai, Wei-Guo Gu, Ming-Bin Hu, Wei-Jia Wang, Shan-Shan Wang, Ya-Jun Huai, Jin-Hong Mei, Chun-Liang Wang. Aging (Albany NY) 2021
0

Cancer immunotherapy with PI3K and PD-1 dual-blockade via optimal modulation of T cell activation signal.
Sho Isoyama, Shigeyuki Mori, Daisuke Sugiyama, Yasuhiro Kojima, Yasuko Tada, Kohei Shitara, Kunihiko Hinohara, Shingo Dan, Hiroyoshi Nishikawa. J Immunother Cancer 2021
0

Human CXCR5+ PD-1+ CD8 T cells in healthy individuals and patients with hematologic malignancies.
Tom Hofland, Anne W J Martens, Jaco A C van Bruggen, Renate de Boer, Sjoerd Schetters, Ester B M Remmerswaal, Frederike J Bemelman, Mark-David Levin, Adriaan D Bins, Eric Eldering,[...]. Eur J Immunol 2021
0

Trials and tribulations of pancreatic cancer immunotherapy.
Daniel R Principe, Murray Korc, Suneel D Kamath, Hidayatullah G Munshi, Ajay Rana. Cancer Lett 2021
4